Business Context and Reporting Period
Company: Icecure Medical Ltd.
Filing Type: Form 6-K (Report of Foreign Private Issuer)
Filing Date: November 19, 2025
Reporting Period: Nine months ended September 30, 2025
Context: This filing incorporates by reference a press release (Exhibit 99.1) detailing the Company's financial and operational results for the specified nine-month period.
Key Financial Metrics
The provided text is a cover sheet for Form 6-K and does not contain specific financial data. The actual figures for revenue, profit, cash flow, margins, debt, and liquidity are located in the attached press release (Exhibit 99.1), which is not included in the input text. Therefore, no specific values can be reported from this document alone.
Material Changes
The filing text does not provide specific details regarding material changes versus prior periods. Such information is contained within the referenced press release (Exhibit 99.1).
Guidance, Outlook, and Risks
The filing text does not include management commentary, guidance, outlook, risks, contingencies, or unusual items. These disclosures are expected to be found in the full text of the press release attached as Exhibit 99.1.
Investor Verification Checklist
- Review Exhibit 99.1 (Press Release dated November 19, 2025) for actual revenue, net loss, and cash burn figures for the nine months ended September 30, 2025.
- Verify the Company's cash and cash equivalents position to assess liquidity runway.
- Check for any updates on clinical trial progress or regulatory milestones mentioned in the press release.
- Confirm if there were any material changes in debt obligations or financing activities during the period.